This invention is directed to an ophthalmic pharmaceutical compositioncomprising as active ingredient a combination of a) glycine and proline; andb) sodium hyaluronate. The composition is suitable for the therapeutic use inthe treatment of corneal ulcerations, and lesions and for dry eye symptoms.